Elrexfio showed higher response rates but shorter PFS compared to Tecvayli in real-world settings for relapsed/refractory ...
Black race, regardless of cytogenetics, was found to be associated with poorer survival in a 30-year retrospective analysis of clinical trials involving patients with acute myeloid leukemia (AML) ...
Obe-cel demonstrates high remission rates in pediatric patients with high-risk r/r B-ALL with overall response rate (ORR) of 95.5%; low rates of ...
Apple recently issued a fresh privacy-focused warning to iPhone users: avoid using Google Chrome (and certain Google apps).
A chemotherapy-free regimen significantly improved outcomes compared with standard therapy for newly diagnosed Ph+ acute ...
Trump’s new National Security Strategy places the main geopolitical focus on the Americas and calls on the region to help ...
Bristol Myers Squibb (NYSE: BMY) reinforces its hematology leadership through new research across multiple therapies for patients with lymphoma at the 67th American Society of Hematology (ASH) Annual ...
A method to address discrepancies between predicted biological age and actual chronological age has been validated as a biomarker in predicting OS.
SINGAPORE,First and only chemotherapy-free combination in the first-line setting to demonstrate an overall survival benefit versus osimertinib among Asian patients.
Mercedes has revealed its second-generation GLB in full, offering seven-seat versatility and almost 400 miles of range. On ...
PlugOS is an Android-based secure operating system that runs entirely inside PlugMate, rather than on the host device. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results